Catheter Precision (VTAK) Non-Current Deffered Revenue (2017 - 2021)

Catheter Precision (VTAK) has 5 years of Non-Current Deffered Revenue data on file, last reported at $566000.0 in Q2 2021.

• Non-Current Deffered Revenue for Q2 2021 came in at $566000.0, down 33.1% year-over-year; the trailing twelve-month figure through Jun 2021 was $566000.0 (down 33.1% YoY), and the FY2020 annual result was $686000.0, down 44.32% from the prior year.
• Non-Current Deffered Revenue eased to $566000.0 in Q2 2021 per VTAK's latest filing, from $617000.0 in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $1.2 million in Q4 2019 and troughed at $566000.0 in Q2 2021.
• A 5-year average of $853153.8 and a median of $775000.0 in 2017 frame the typical range for Non-Current Deffered Revenue.
• The sharpest annual moves came in 2019 and 2020: Non-Current Deffered Revenue surged 60.63% in 2019, then tumbled 44.32% in 2020.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $775000.0 in 2017, then retreated by 1.03% to $767000.0 in 2018, then surged by 60.63% to $1.2 million in 2019, then plunged by 44.32% to $686000.0 in 2020, then fell by 17.49% to $566000.0 in 2021.
• Business Quant data shows VTAK's Non-Current Deffered Revenue at $566000.0 in Q2 2021, $617000.0 in Q1 2021, and $686000.0 in Q4 2020.